§ Funding Round
Regentis Biomaterials raised $15M Series D venture round, led by haisco pharmaceutical group.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$25M
Top Valuation
-
Regentis Biomaterials raised $15M in a Series D round.
The round was announced on 02/11/16.
The round was led by haisco pharmaceutical group.
